Also trades as: 0H7S.L (LSE)
ABMD NASDAQ
Abiomed, Inc.
1W: +0.0%
1M: +0.9%
3M: +57.1%
1Y: +8.2%
3Y: +121.1%
5Y: +99.9%
$381.02
Last traded 2022-12-23 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$1B
Revenue
+10.3% YoY
$267M
Net Income
+78.9% YoY
$217M
Free Cash Flow
-6.9% YoY
81.6%
Gross Margin
21.8%
Op. Margin
39.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE18.2%
ROA16.5%
ROIC27.6%
Valuation
P/E127.0
P/B11.5
EV/EBITDA22.2
Leverage
Debt/Equity0.00
Current Ratio7.93
Interest Cov.4.7x
Quality Scores
Piotroski F6/9
Altman Z46.06
Beneish M-2.42